Brian D. Hitt

1.7k total citations
14 papers, 1.4k citations indexed

About

Brian D. Hitt is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Brian D. Hitt has authored 14 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 7 papers in Molecular Biology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Brian D. Hitt's work include Alzheimer's disease research and treatments (12 papers), Neuroscience and Neuropharmacology Research (5 papers) and Prion Diseases and Protein Misfolding (2 papers). Brian D. Hitt is often cited by papers focused on Alzheimer's disease research and treatments (12 papers), Neuroscience and Neuropharmacology Research (5 papers) and Prion Diseases and Protein Misfolding (2 papers). Brian D. Hitt collaborates with scholars based in United States, Belgium and Germany. Brian D. Hitt's co-authors include Robert Vassar, Kim N. Green, Frank M. LaFerla, Ian F. Smith, Erika Maus, Tracy O’Connor, William A. Eimer, Yama Akbari, Angelo Demuro and Ian Parker and has published in prestigious journals such as Journal of Biological Chemistry, Neuron and Journal of Neuroscience.

In The Last Decade

Brian D. Hitt

14 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian D. Hitt United States	9	998	544	436	367	269	14	1.4k
Simone Eggert Germany	19	1.3k 1.3×	845 1.6×	466 1.1×	315 0.9×	328 1.2×	30	1.7k
Vicki Olm United States	8	1.2k 1.2×	704 1.3×	395 0.9×	291 0.8×	182 0.7×	8	1.7k
Alejandra Alonso Netherlands	7	955 1.0×	596 1.1×	364 0.8×	223 0.6×	222 0.8×	15	1.3k
Paul Fraser Canada	15	1.4k 1.4×	879 1.6×	420 1.0×	348 0.9×	481 1.8×	18	1.8k
Xénia Latypova France	7	797 0.8×	642 1.2×	280 0.6×	259 0.7×	132 0.5×	15	1.3k
Pavan Krishnamurthy United States	14	985 1.0×	582 1.1×	546 1.3×	273 0.7×	176 0.7×	23	1.7k
Jian–Zhi Wang China	20	867 0.9×	759 1.4×	389 0.9×	249 0.7×	151 0.6×	39	1.7k
Ismael Santa‐María United States	22	945 0.9×	816 1.5×	334 0.8×	254 0.7×	155 0.6×	46	1.7k
Nathalie Pierrot Belgium	21	881 0.9×	641 1.2×	396 0.9×	217 0.6×	136 0.5×	30	1.4k
Kanae Ando Japan	19	856 0.9×	681 1.3×	273 0.6×	185 0.5×	309 1.1×	49	1.3k

Countries citing papers authored by Brian D. Hitt

Since Specialization

Citations

This map shows the geographic impact of Brian D. Hitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian D. Hitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian D. Hitt more than expected).

Fields of papers citing papers by Brian D. Hitt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian D. Hitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian D. Hitt. The network helps show where Brian D. Hitt may publish in the future.

Co-authorship network of co-authors of Brian D. Hitt

This figure shows the co-authorship network connecting the top 25 collaborators of Brian D. Hitt. A scholar is included among the top collaborators of Brian D. Hitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian D. Hitt. Brian D. Hitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Adams, Jenna N., et al.. (2024). The amyloid beta 42/38 ratio as a plasma biomarker of early memory deficits in cognitively unimpaired older adults. Neurobiology of Aging. 144. 12–18. 1 indexed citations

Yu, Fang, Bryan D. Ryder, Brian D. Hitt, et al.. (2024). Differentiation and characterization of healthy versus pathological tau using chemical exchange saturation transfer. NMR in Biomedicine. 37(9). e5160–e5160. 2 indexed citations

Hitt, Brian D., Ankit Gupta, Ting Yang, et al.. (2023). Anti-tau antibodies targeting a conformation-dependent epitope selectively bind seeds. Journal of Biological Chemistry. 299(11). 105252–105252. 8 indexed citations

Artikis, Efrosini, Brian D. Hitt, Sandi Jo Estill, et al.. (2023). Tau seeding without tauopathy. Journal of Biological Chemistry. 300(1). 105545–105545. 6 indexed citations

Hitt, Brian D., Ting Yang, Ping Shang, et al.. (2022). Conformation‐specific anti‐tau antibodies distinguish human tauopathies. Alzheimer s & Dementia. 18(S4). 1 indexed citations

Hitt, Brian D., et al.. (2021). Ultrasensitive tau biosensor cells detect no seeding in Alzheimer’s disease CSF. Acta Neuropathologica Communications. 9(1). 99–99. 39 indexed citations

Hitt, Brian D., Sean M. Riordan, Lokesh Kukreja, et al.. (2012). β-Site Amyloid Precursor Protein (APP)-cleaving Enzyme 1 (BACE1)-deficient Mice Exhibit a Close Homolog of L1 (CHL1) Loss-of-function Phenotype Involving Axon Guidance Defects. Journal of Biological Chemistry. 287(46). 38408–38425. 122 indexed citations

Hitt, Brian D., Thomas C. Jaramillo, Dane M. Chetkovich, & Robert Vassar. (2010). BACE1-/- mice exhibit seizure activity that does not correlate with sodium channel level or axonal localization. Molecular Neurodegeneration. 5(1). 31–31. 79 indexed citations

O’Connor, Tracy, Katherine R. Sadleir, Erika Maus, et al.. (2008). Phosphorylation of the Translation Initiation Factor eIF2α Increases BACE1 Levels and Promotes Amyloidogenesis. Neuron. 60(6). 988–1009. 344 indexed citations

10.

Green, Kim N., Angelo Demuro, Yama Akbari, et al.. (2008). SERCA pump activity is physiologically regulated by presenilin and regulates amyloid β production. The Journal of Cell Biology. 181(7). 1107–1116. 248 indexed citations

11.

Green, Kim N., Angelo Demuro, Yama Akbari, et al.. (2008). SERCA pump activity is physiologically regulated by presenilin and regulates amyloid β production. The Journal of General Physiology. 132(2). i1–i1. 19 indexed citations

12.

Zhao, Jie, Yifan Fu, Marina V. Yasvoina, et al.. (2007). β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Levels Become Elevated in Neurons around Amyloid Plaques: Implications for Alzheimer's Disease Pathogenesis. Journal of Neuroscience. 27(14). 3639–3649. 316 indexed citations

13.

Smith, Ian F., Brian D. Hitt, Kim N. Green, Salvatore Oddo, & Frank M. LaFerla. (2005). Enhanced caffeine‐induced Ca²⁺release in the 3xTg‐AD mouse model of Alzheimer's disease. Journal of Neurochemistry. 94(6). 1711–1718. 144 indexed citations

14.

Akbari, Yama, Brian D. Hitt, M. Paul Murphy, et al.. (2004). Presenilin regulates capacitative calcium entry dependently and independently of γ-secretase activity. Biochemical and Biophysical Research Communications. 322(4). 1145–1152. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact